₹663.05
-0.14% today
· 30d -3.98%
as of 2026-09-04
Price · Daily Candles
“DIIs step up MedPlus stake as FIIs trim holdings, sparking sector valuation debate.”
MedPlus recorded strong annual net profit growth of +46.18% to ₹220 Cr for FY26, with a 3-year net profit CAGR of 64.02%. However, its TTM PE of 48.22 stands significantly higher than its sole peer SASTASUNDR, which has an undefined PE and negative ROCE.
BULL CASE
+Net profit surged +46.18% YoY to ₹220 Cr for the fiscal year ending March 2026, alongside a 12.33% revenue increase to ₹6892 Cr.
+Quarterly revenue grew +23.5% YoY to ₹1864 Cr and net profit increased +24.66% to ₹64 Cr for Q4 FY26.
+The 3-year net profit CAGR stands at an impressive 64.02% (from March 2023 to March 2026).
+DIIs increased their stake by 1.25% QoQ, holding 27.82% as of March 2026.
BEAR CASE
−FIIs reduced their holding by 1.3% QoQ to 15.53% as of March 2026.
−The stock is trading at a TTM PE of 48.22, significantly higher than its sector peer SASTASUNDR (PE undefined, ROCE -22.86%).
−Its ROCE of 13.0% appears modest given the high valuation.
−The ML model predicts weak growth for FCF, with all three lookback horizons (recent 2yr, rolling 4yr, stable 7yr) having ranks below 0.5.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹1880 Cr
+21.84% YoY
NET PROFIT
₹33 Cr
-21.67% YoY
OPM
8.06%
-1.3pp YoY
EPS
₹2.76
PE 48.22
Intrinsic value · DCF ₹441.56 · Margin of safety -33.4% (overvalued) · FCF yield 4.7%
◇ Sector Position
MedPlus commands a TTM PE of 48.22 with a ROCE of 13.0%, while its peer SASTASUNDR's PE is undefined and shows a negative ROCE of -22.86%, highlighting a valuation disparity in the Pharmaceutical Retailers sector.
PEERPEROCE %
MEDPLUS48.2213.0
ML Forward Growth Predictions 🔒
52
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
UNDERPERFORMER
20
Valuation
FAIR
40
Growth
STRONG
73
Profitability
DECENT
58
Technicals
WEAK
33
Risk
LOW
90
Key Stats
TTM PE
48.22
P/B
5.36
52W HIGH
₹1022.2
OFF HIGH
-35.14%
MKT CAP
₹7921 Cr
◉ Active Signals
MACDNeutral3.1544
RSI(14)Bearish37.49
Near 52W LowBearish2.32
Street Consensus
7 analysts₹1163.0
mean target
Low ₹1060.0Now ₹663.05High ₹1271.0
⧉ Strategy Fit 🔒